Sharing-our-perspective-page-header2



Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward



  • Lyrica® generic may be delayed

    by
    | Aug 21, 2018
    Tag Icon
    Workers' Compensation, Generics
    The patent for Lyrica® (pregabalin) was originally expected to expire at the end of 2018, making way for generic pregabalin to become available to consumers. But recent developments indicate that the patent may be extended


  • Pfizer defers July 2018 price increases

    by
    • Optum Workers' Comp
    | Aug 16, 2018
    Tag Icon
    Diabetes, Pain Management, Workers' Compensation
    Pfizer announced that their July 1 medication price increases were rolled back due to market pressures. The intended price increases are not permanently suspended and Pfizer has stated that they have only been deferred until the end of the year.


  • Missouri enacts opioid prescribing limits

    by
    • Optum
    | Aug 09, 2018
    Tag Icon
    Workers' Compensation, Pain Management, Opioids, Government Affairs
    The Missouri Legislature, in the waning hours of its session, passed legislation containing numerous changes to existing laws governing medical and pharmacy practices. One tucked away segment of the bill imposes prescribing restrictions for initial prescriptions of opioids to treat acute pain.


  • U.S. Department of Justice announces new opioid diversion rule

    by
    • Optum Workers' Comp
    | Jul 20, 2018
    Tag Icon
    DEA, Workers' Compensation, Opioids, Government Affairs, Addiction
    In a step to combat the opioid epidemic, the United States Department of Justice (DOJ) recently announced final adoption and publication of a new rule related to drug diversion and opioid production limits.




Questions for our
Government Affairs team? 







Subscribe

Stay informed by signing up to receive our latest updates.